Dr. Xiaoping Wu obtained her Bachelor and PhD in Pharmacology at the China Pharmaceutical University and the University of Hong Kong (HKU), respectively. She received her post-doctoral training in the Department of Pharmacology and Pharmacy at HKU. She is currently a research assistant professor in the department. Her research focuses on obesity-related metabolic diseases and the role of adipokines under both physiological and pathological conditions.

Memberships & Editorships

• Ordinary Member of Hong Kong Society of Endocrinology, Metabolism, and Reproduction
• Member of the State Key Laboratory of Pharmaceutical Biotechnology, The University of Hong Kong

• Member of Young Editor Board of Chinese Medicine

Honours and Awards

• Young Investigator Award: 15^th International Symposium on Healthy Aging “Towards Enduring Youth” (Hong Kong, 2021)

• Identification of therapeutic targets for metabolic diseases including type 2 diabetes, type 1 diabetes, and liver diseases.
• Lipid metabolism in adipose tissue and the liver.
• Evaluation of therapeutic effects of natural products in cancer-related diseases.